Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report

Sandhya Khurana; Andrew Bush; Fernando Holguin

doi:10.1183/20734735.0058-2020

Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report

Breathe (Sheff). 2020 Jun;16(2):200058. doi: 10.1183/20734735.0058-2020.

Authors

Sandhya Khurana¹, Andrew Bush², Fernando Holguin³

Affiliations

¹ University of Rochester School of Medicine and Dentistry, Pulmonary and Critical Care Medicine, Rochester, NY, USA.
² Dept of Paediatrics, National Heart & Lung Institute, Imperial College London, London, UK.
³ University of Colorado, Pulmonary Sciences and Critical Care Medicine, Denver, CO, USA.

Abstract

Educational aims This article is mainly intended for trainees and specialists who are interested in the management of severe asthma. It aims to inform readers about the updated ERS/ATS recommendations for management of severe asthma, specifically on the topics of biologics, macrolides and long-acting muscarinic antagonists.It also provides guidance on utilisation of available biomarkers in selecting advanced therapies in severe asthma.

Publication types

Review